AI assistant
Sending…
Edesa Biotech, Inc. — Director's Dealing 2019
Jun 11, 2019
35006_dirs_2019-06-11_9a0ae637-cc25-4e77-b09b-1636efd364ce.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Edesa Biotech, Inc. (EDSA)
CIK: 0001540159
Period of Report: 2019-06-07
Reporting Person: Sistilli Carlo (Director)
More from Edesa Biotech, Inc.
Regulatory Filings
2026
May 29
Regulatory Filings
2026
May 29
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 14
Annual Report
2026
Apr 3
Proxy Solicitation & Information Statement
2026
Apr 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 2
Director's Dealing
2026
Mar 2